NCT02195284 - To Study Device Attributes by Investigating Errors Made in Use, Ease of Use and Preference Among Different Inhalers in Subjects With Asthma | Biotech Hunter

Enrollment

162

Participants

Timeline

Start Date

November 30, 2014

Primary Completion Date

May 31, 2015

Study Completion Date

May 31, 2015

Conditions

Asthma

Interventions

DEVICE

ELLIPTA

Dry powder inhaler (placebo) with two blister strips. One placebo strip containing lactose monohydrate and a second placebo strip containing lactose monohydrate blended with magnesium stearate

DEVICE

DISKUS/ACCUHALER

Placebo inhaler with one blister strip containing lactose monohydrate.

DEVICE

MDI

Placebo inhaler containing propellant (1,1,1, 2-Tetrafluoroethane)

DEVICE

TURBUHALER

Placebo inhaler containing lactose monohydrate.

Trial Locations (4)

7513 ER

GSK Investigational Site, Enschede

7207 AE

GSK Investigational Site, Zutphen

PO6 3LY

GSK Investigational Site, Portsmouth

SO16 6YD

GSK Investigational Site, Southampton